title: Obese and diabetic patients with end-stage renal disease: Peritoneal dialysis or hemodialysis?
abstract: Obesity is a chronic disease that is increasingly prevalent around the world and is a well-recognized risk factor for type 2 diabetes and hypertension, leading causes of end-stage renal disease (ESRD). The obese diabetic patient with ESRD is a challenge for the nephrologist with regard to the type of renal replacement therapy that should be suggested and offered to the patient. There is no evidence that either peritoneal dialysis or hemodialysis is contraindicated in obese ESRD patients. In the literature, we can find a discrepancy in the impact of obesity on mortality among hemodialysis vs. peritoneal dialysis patients. Several studies in hemodialysis patients suggest that a higher BMI confers a survival advantage - the so-called "reverse epidemiology". In contrast, the literature among obese peritoneal dialysis patients is inconsistent, with various studies reporting an increased risk of death, no difference, or a decreased risk of death. Many of these studies only spanned across a few years, and this is probably too short of a time frame for a realistic assessment of obesity's impact on mortality in ESRD patients. The decision for dialysis modality in an obese diabetic patient with ESRD should be individualized. According to the results of published studies, we cannot suggest PD or HD as a better solution for all obese diabetic patients. The obese patient should be educated about all their dialysis options, including home dialysis therapies. In this review, the available literature related to the dialysis modality in obese patients with diabetes and ESRD was reviewed.
authors.affiliation: University Medical Centre Maribor, Clinic for Internal Medicine, Department of Dialysis, Maribor, Slovenia; University of Maribor, Faculty of Medicine, Maribor, Slovenia. Electronic address: robert.ekart2@guest.arnes.si.
authors.forename: Robert
authors.initials: R
authors.lastname: Ekart
authors.affiliation: University of Maribor, Faculty of Medicine, Maribor, Slovenia; University Medical Centre Maribor, Clinic for Internal Medicine, Department of Nephrology, Maribor, Slovenia.
authors.forename: Radovan
authors.initials: R
authors.lastname: Hojs
mesh_terms: D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D009765:Obesity / Q000150:complications*; D010530:Peritoneal Dialysis / Q000379:methods*; D006435:Renal Dialysis / Q000379:methods; D015996:Survival Rate; D016896:Treatment Outcome
keywords: End-stage renal disease; Hemodialysis; Obesity; Peritoneal dialysis